2017
DOI: 10.1186/s13075-017-1304-2
|View full text |Cite
|
Sign up to set email alerts
|

Tie2 as a novel key factor of microangiopathy in systemic sclerosis

Abstract: BackgroundThe angiopoietin(Ang)/Tie2 system is a key regulator of vascular biology. The expression of membrane bound (mb) Tie2 and Ang-1 ensures vessel stability, whereas Ang-2, inducible by vascular endothelial growth factor (VEGF), hypoxia, and inflammation, acts as an antagonist. Tie2 signalling is also attenuated by soluble Tie2 (sTie2), the extracellular domain of the receptor, which is shed upon stimulation with VEGF. Herein, we investigate the role of Ang/Tie2 in the peripheral vasculopathy in systemic … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
18
0

Year Published

2018
2018
2024
2024

Publication Types

Select...
6
2

Relationship

1
7

Authors

Journals

citations
Cited by 26 publications
(19 citation statements)
references
References 30 publications
1
18
0
Order By: Relevance
“…However, noting the results of a recent study, there is a reduction in Ang-1/-2 ratio in serum of both pre-SSc and SSc with particular association with DU history [93]. Furthermore, increased vascular expression of Ang-2, reduced Tie2 and comparable Ang-1 in SSc skin versus controls [93] potentially represents a shift towards an anti-angiogenic environment. Progressive study regarding the association of Ang-2 with VEGF-Axxxb isoforms may help map the divergent nature of Ang-2 with VEGF-A expression and the implications of VEGF-A isoforms on angiopoietin function.…”
Section: Additional Mediators Implicated In Enhanced Vegf-a Signalingmentioning
confidence: 86%
See 2 more Smart Citations
“…However, noting the results of a recent study, there is a reduction in Ang-1/-2 ratio in serum of both pre-SSc and SSc with particular association with DU history [93]. Furthermore, increased vascular expression of Ang-2, reduced Tie2 and comparable Ang-1 in SSc skin versus controls [93] potentially represents a shift towards an anti-angiogenic environment. Progressive study regarding the association of Ang-2 with VEGF-Axxxb isoforms may help map the divergent nature of Ang-2 with VEGF-A expression and the implications of VEGF-A isoforms on angiopoietin function.…”
Section: Additional Mediators Implicated In Enhanced Vegf-a Signalingmentioning
confidence: 86%
“…Under normoxic conditions, Ang-1 aims to maintain vessel stability through Tie2 signaling, whilst Ang-2 is released under hypoxic stress and acts differentially to either facilitate angiogenesis or angio-regression depending on the presence or absence of VEGF-A respectively [93]. Reported circulating levels of angiopoietins and Tie2 are variable in the literature [84,88,[93][94][95][96]. However, noting the results of a recent study, there is a reduction in Ang-1/-2 ratio in serum of both pre-SSc and SSc with particular association with DU history [93].…”
Section: Additional Mediators Implicated In Enhanced Vegf-a Signalingmentioning
confidence: 99%
See 1 more Smart Citation
“…These findings are consistent with elevated Tie2 expression in human RA synovium [ 18 ]. In addition, serum Tie-2 levels were found increased in systemic sclerosis (SSc), another complex disease characterized by widespread microangiopathy [ 19 , 20 ]. Moreover, a dysregulation of Ang/Tie2 was observed in the bleomycin mouse model, reflecting early and inflammatory stages of SSc, which did not apply for the non-inflammatory tight skin mouse model, highlighting the link between Tie-2 and inflammation, as it was observed in our study [ 19 ].…”
Section: Discussionmentioning
confidence: 99%
“…41,42 Furthermore, it is currently unknown whether these recently detected Tie2+ cells in the IVD could play a central role in inflammation and IVD degeneration as Tie2 signaling has been linked to mechanism of systemic inflammation and microangio-related pathologies. 43,44 These Tie2+ cells might be a critical element to understand pathologies of the IVD and to develop novel therapeutic perspectives using tissue-engineered constructs.…”
Section: Limitationsmentioning
confidence: 99%